High Sensitive C-Reactive Protein as a Marker of Systemic Inflammation in Male Coronary Artery Disease with Obstructive Sleep Apnea
DOI:
https://doi.org/10.36497/jri.v41i2.176Keywords:
hsCRP, coronary artery disease, obstructive sleep apneaAbstract
Background: High Sensitive C-Reactive Protein (hsCRP) is an acute phase protein which may be used as a sensitive marker for increased risk of cardiovascular events in Obstructive Sleep Apnea (OSA) subjects.
Methods: This was a cross-sectional study to evaluate hsCRP as a sensitive marker for cardiovascular events in Obstructive Sleep Apnea (OSA) subjects. Subjects were recruited at Medical Check-up Department, Siloam Hospital Lippo Village, Karawaci, Tangerang between January and December 2018. This study included 74 OSA men whose blood were collected after fasting prior to hsCRP test. The diagnosis of Coronary Artery Disease (CAD) was determined by previous medical examinations using treadmill test, CT angiography and cardiac catheterization.
Results: There were 39 people (52,7%) who were diagnosed with CAD out of 74 OSA men. The cut off point for hsCRP more than 0,42 was a marker for increased risk for CAD with Odds Ratio (OR)=7,43, Relative Risk (RR)=88%, sensitivity=17,95%, specificity=97,14%, Likelihood ratio (LR+) 6,28 and LR(-) 0,84.
Conclusion: HsCRP with cut-off point >0,42 could be used as a marker of increased risk of cardiovascular case in male OSA subjects.Downloads
References
Monahan K, Redline S. Role of obstructive sleep apnea in cardiovascular disease. Curr Opin Cardiol. 2011;26(6):541–7.
Sforza E, Roche F. Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach. Hypoxia. 2016;4:99–108.
Javaheri S, Javaheri S, Javaheri A. Sleep apnea, heart failure, and pulmonary hypertension. Curr Heart Fail Rep. 2013;10(4):315–20.
Mokhlesi B, Ham SA, Gozal D. The effect of sex and age on the comorbidity burden of OSA: An observational analysis from a large nationwide US health claims database. Eur Respir J. 2016;47(4):1162–9.
Kasai T, Floras JS, Bradley TD. Sleep apnea and cardiovascular disease: A bidirectional relationship. Circulation. 2012;126(12):1495–510.
Bennett NR, Ferguson TS, Bennett FI, Tulloch-Reid MK, Younger-Coleman NOM, Jackson MD, et al. High-Sensitivity C-Reactive Protein is Related to Central Obesity and the Number of Metabolic Syndrome Components in Jamaican Young Adults. Front Cardiovasc Med. 2014;1(December):1–9.
Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, et al. High-sensitivity C-reactive protein and cardiovascular disease: A resolute belief or an elusive link? J Am Coll Cardiol. Elsevier Inc; 2013;62(5):397–408.
Tan A, Yin JDC, Tan LWL, Van Dam RM, Cheung YY, Lee CH. Using the Berlin questionnaire to predict obstructive sleep apnea in the general population. J Clin Sleep Med. 2017;13(3):427–32.
Berry R, Budhiraja R, Gottlieb D, Gozal D, Iber C, Kapur V, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. J Clin Sleep Med. 2012;8(5):597–619.
Sateia MJ. International classification of sleep disorders-third edition highlights and modifications. Chest. 2014;146(5):1387–94.
Joseph J, Velasco A, Hage FG, Reyes E. Guidelines in review: Comparison of ESC and ACC/AHA guidelines for the diagnosis and management of patients with stable coronary artery disease. J Nucl Cardiol. Springer US; 2018;25(2):509–15.
Heinzer R, Vat S, Marques-Vidal P. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3:310–18.
Mandal S, Kent BD. Obstructive sleep apnoea and coronary artery disease. J Thorac Dis. 2018;10(S34):S4212–20.
Xu XM, Yao D, Cai XD, Ding C, Lin QD, Wang LX, et al. Effect of chronic continual- and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats. Sleep Breath. 2015;19(2):677–84.
Zeng X, Guo R, Dong M, Zheng J, Lin H, Lu H. Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression. J Transl Med. BioMed Central; 2018;16(1):1–11.
Ren H, Hu K. Infammatory and oxidative stress-associated factors in chronic intermittent hypoxia in Chinese patients, rats, lymphocytes and endotheliocytes. Mol Med Rep. 2017;16(6):8092–102.
Higashi Y, Maruhashi T, Noma K, Kihara Y. Oxidative stress and endothelial dysfunction: Clinical evidence and therapeutic implications. Trends Cardiovasc Med. Elsevier; 2014;24(4):165–9.
Kim J, Lee SJ, Choi KM, Lee SK, Yoon DW, Lee SG, et al. Obstructive sleep apnea is associated with elevated high sensitivity C-reactive protein levels independent of obesity: Korean genome and epidemiology study. PLoS One. 2016;11(9):1–15.
Chirag M Lakhani, Braden T Tierney, Arjun K Manrai, Jian Yang, Peter M Visscher CJP. Serum from obstructive sleep apnea patients induces inflammatory responses in coronary artery endothelial cells. Physiol Behav. 2019;176(3):139–48.
Li K, Wei P, Qin Y, Wei Y. Is C-reactive protein a marker of obstructive sleep apnea? Med (United States). 2017;96(19).
Firat Guven S, Turkkani MH, Ciftci B, Ulukavak Ciftci T, Erdogan Y. The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Sleep Breath. 2012;16(1):217–21.
Chung S, Yoon IY, Shin YK, Chul HL, Kim JW, Lee T, et al. Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome. Sleep. 2007;30(8):997–1001.
Randerath W, Bonsignore MR, Herkenrath S. Obstructive sleep apnoea in acute coronary syndrome. Eur Respir Rev. 2019;28(153):1–15.
Mooe T, Franklin K, Holmstr K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med. 2001;164(10):1910–1913.
De Torres-Alba F, Gemma D, Armada-Romero E, Rey-Blas JR, López-De-Sá E, López-Sendon JL. Obstructive sleep apnea and coronary artery disease: From pathophysiology to clinical implications. Pulm Med. 2013;2013.
Downloads
Additional Files
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
